Track topics on Twitter Track topics that are important to you
Mercer, a global consulting leader in advancing health, wealth and career, and a wholly owned subsidiary of Marsh & McLennan Companies (NYSE: MMC), announced the appointment of Scott Grenn as Office Business Leader, Health in Northern California. In this role, he will consult with clients, drive revenue growth and build Mercer’s brand and market awareness across Northern California. Mr. Grenn will report to Trisha Tyler, West Market Business Leader, Health. He is based in Mercer’s San Francisco office.
“We are excited to welcome Scott to this role,” said Ms. Tyler. “His leadership experience and industry knowledge will help us further provide exceptional service and solutions to our clients while strategically growing our business in Northern California.”
Mr. Grenn has more than 25 years of industry experience, including extensive work in the large employer market. Prior to this role, he was a Principal and Senior Consultant at Mercer with a primarily focus on long-term benefit strategy, design and execution. Before joining Mercer, Mr. Grenn spent nine years with BridgeStreet Consulting Group. Scott earned his BA in Finance from California State University, Chico.
Mercer delivers advice and technology-driven solutions that help organizations meet the health, wealth and career needs of a changing workforce. Mercer’s more than 25,000 employees are based in 44 countries and the firm operates in over 130 countries. Mercer is a business of Marsh & McLennan Companies (NYSE: MMC), the world’s leading professional services firm in the areas of risk, strategy and people with 76,000 colleagues and annualized revenue approaching $17 billion. Through its market-leading businesses including Marsh, Guy Carpenter and Oliver Wyman, Marsh & McLennan helps clients navigate an increasingly dynamic and complex environment. For more information, visit www.mercer.com. Follow Mercer on Twitter @Mercer.
+1 212 345 0806
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...
Multiple Sclerosis MS
Multiple sclerosis (MS) is the most common disabling neurological condition affecting 100,000 young adults in the UK. The condition results from autoimmune damage to myelin, causing interference in nerve signaling. Symptoms experienced depend on the pa...